

#2372 - Garry Nolan
343 snips Aug 28, 2025
Garry Nolan, an immunologist at Stanford and director of the Sol Foundation, dives into the battle between the immune system and cancer. He shares insights on how tumors evade detection, challenges in organ transplantation, and innovations in personalized medicine like CRISPR. The conversation also touches on the intersection of AI and immunology, the implications of UAP studies, and the necessity for open dialogue around extraordinary claims, all suggesting a future where science and technology converge in unimaginable ways.
AI Snips
Chapters
Books
Transcript
Episode notes
How Tumors Outsmart Immunity
- Tumors evolve to trick the immune system and even harness inflammation to grow.
- Reactivating immune recognition is key to stopping progression and metastasis.
Tracing Cancer With High-Dimensional Data
- Measuring dozens of protein markers lets you trace cancer cell development paths.
- Stitching snapshots with pseudotime reveals steps to target different leukemia subtypes.
Match Diagnostics To Subtypes First
- Personalize cancer treatment by matching diagnostics to disease subtypes before prescribing.
- Use subtype diagnostics to pick therapies with higher expected benefit for that patient.